Class II peptide multimers: promise for type 1A diabetes?

被引：0
|
作者：
George S. Eisenbarth
Gerald T. Nepom
机构：
[1] Barbara Davis Center for Childhood Diabetes,
[2] University of Colorado,undefined
[3] Benaroya Research Institute,undefined
来源：
Nature Immunology | 2002年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Lack of proper tools hampers early diagnosis and treatment of antigen-specific autoimmune diseases. A new strategy that makes use of peptide-MHC reagents could control recent-onset diabetes in mice.
引用
收藏
页码：344 / 345
页数：1
相关论文
共 50 条
  • [1] Class II peptide multimers: promise for type 1A diabetes?
    Eisenbarth, GS
    Nepom, GT
    NATURE IMMUNOLOGY, 2002, 3 (04) : 344 - 345
  • [2] HLA-class II and class I genotypes among Japanese children with Type 1A diabetes and their families
    Sugihara, Shigetaka
    Ogata, Tsutomu
    Kawamura, Tomoyuki
    Urakami, Tatsuhiko
    Takemoto, Koji
    Kikuchi, Nobuyuki
    Takubo, Noriyuki
    Tsubouchi, Kohji
    Horikawa, Reiko
    Kobayashi, Kisho
    Kasahara, Yoshihito
    Kikuchi, Tohru
    Koike, Akemi
    Mochizuki, Takahiro
    Minamitani, Kanshi
    Takaya, Ryuzo
    Mochizuki, Hiroshi
    Nishii, Aki
    Yokota, Ichiro
    Kizaki, Zenro
    Mori, Tetsuo
    Shimura, Naoto
    Mukai, Tokuo
    Matsuura, Nobuo
    Fujisawa, Takao
    Ihara, Kenji
    Kosaka, Kitaro
    Kizu, Rika
    Takahashi, Toshikazu
    Matsuo, Satoshi
    Hanaki, Keiichi
    Igarashi, Yutaka
    Sasaki, Goro
    Soneda, Shun
    Teno, Shinichi
    Kanzaki, Susumu
    Saji, Hiroh
    Tokunaga, Katsushi
    Amemiya, Shin
    PEDIATRIC DIABETES, 2012, 13 (01) : 33 - 44
  • [3] Genetics of type 1A diabetes
    Redondo, MJ
    Fain, PR
    Eisenbarth, GS
    RECENT PROGRESS IN HORMONE RESEARCH, VOL 56, 2001, 56 : 69 - 89
  • [4] Genetics of Type 1A Diabetes
    Concannon, Patrick
    Rich, Stephen S.
    Nepom, Gerald T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (16): : 1646 - 1654
  • [5] The stages of type 1A diabetes
    Babaya, N
    Nakayama, M
    Eisenbarth, GS
    AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 : 194 - 204
  • [6] Phase II results shows promise for Type 1 diabetes drug
    Patience, Jonny
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (10) : 896 - 897
  • [7] Heterogeneity in risk of progression to type 1A diabetes in monozygotic twins of patients with type 1A diabetes
    Redondo, MJ
    MacKenzie, T
    Yu, LP
    Hawa, M
    Pyke, DA
    Eisenbarth, GS
    Leslie, DG
    DIABETES, 2001, 50 : A494 - A494
  • [8] Different contribution of class IIHLA in fulminant and typical autoimmune Type 1 (Type 1A) diabetes.
    Imagawa, A
    Hanafusa, T
    Uchigata, Y
    Kanatsuka, A
    Kawasaki, E
    Kobayashi, T
    Shimada, A
    Shimizu, I
    Maruyama, T
    Makino, H
    DIABETOLOGIA, 2003, 46 : A108 - A108
  • [9] A-type natriuretic peptide level in angiotensin II type 1A receptor knockout mice
    Suzuki, S
    Mifune, H
    Honda, J
    Sugaya, T
    Miyahara, K
    JOURNAL OF HYPERTENSION, 2000, 18 : S72 - S72
  • [10] A-Type Natriuretic Peptide Level in Angiotensin II Type 1a Receptor Knockout Mice
    Mifune, Hiroharu
    Nishi, Yoshihiro
    Tajiri, Yuji
    Yabuki, Akira
    EXPERIMENTAL ANIMALS, 2012, 61 (02) : 131 - 138
12345